University of Hertfordshire

View graph of relations

Key findings

ORM NCE dose dependently (10-80mgkg po, single dose) reverses allodynia in STZ diabetic neuropathy model in line with Pregabalin and ORM positive control.
PKPD determined.

Identified the potential of targeting TRPA1 receptors in type 1 diabetic neuropathic pain.

StatusFinished
Period31/07/1730/08/17

ID: 12452261